合成生物学の世界市場レポート 2025年

合成生物学の市場規模は今後数年で急成長が見込まれます。2029年にはCAGR19.4％で542億7,000万米ドルに成長します。予測期間の成長は、政府のイニシアティブの高まり、代替燃料の需要、遺伝子組み換え作物に対する需要の増加、非公開会社への投資の増加などに起因すると考えられます。予測期間の主な動向には、戦略的提携やパートナーシップ、ヌクレオチド合成とシーケンシングの自動化、遺伝子編集への注目の高まり、無細胞技術の採用が高まる製品革新、バイオ燃料生産のための環境に優しい新プロセスなどがあります。

研究開発（R&D）への投資の増加は、今後の合成生物学市場の成長を促進すると予想されます。研究開発には、既存の製品を強化したり、新しい製品を開発したりするために、新しい知識、技術、製品を生み出すことを目的とした体系的な調査、実験、革新が含まれます。研究開発投資の増加は、競争の激化、技術革新の需要、技術の進歩、消費者の嗜好の変化や市場力学の進化に企業が適応する必要性などが主な原因となっています。合成生物学の研究開発への投資は、特定の用途のために生物学的システムや生物をエンジニアリングすることによって、ヘルスケア、農業、環境管理における持続可能なソリューションを生み出すこの分野の潜在力を引き出すために極めて重要です。例えば、2024年2月、英国の政府機関である国家統計局の報告書によると、2022年の英国における企業全体の研究開発への貢献は医薬品製品グループがトップで、117億米ドル（90億英ポンド）を占めました。この数字は、英国企業が実施する研究開発全体の17.9%に相当します。したがって、研究開発投資の増加が合成生物学市場の成長を牽引しています。

個別化医療に対する需要の高まりが、合成生物学市場の成長を後押しします。個別化医療は精密医療とも呼ばれ、個々の患者の特性に合わせた治療法のカテゴリを構成します。合成生物学は、個人の遺伝的・分子的プロファイルに基づいて治療や介入をカスタマイズするための強力なツールや技術を提供し、個別化医療において重要な役割を果たしています。例えば、2023年、個別化医療連合（Personalized Medicine Coalition）は、2022年にFDAが新薬の34%について個別化医療を承認したと報告しました。それ以前の8年間では、新薬の少なくとも25%に個別化治療薬が承認されていました。このように、個別化医療に対する需要の高まりは、合成生物学市場成長の重要な促進要因となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界合成生物学 PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の合成生物学市場：成長率分析
• 世界の合成生物学市場の実績：規模と成長, 2019-2024
• 世界の合成生物学市場の予測：規模と成長, 2024-2029, 2034F
• 世界合成生物学総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の合成生物学市場：技術別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ヌクレオチド合成と配列決定
• バイオインフォマティクス
• マイクロ流体
• 遺伝子工学
• 世界の合成生物学市場：製品タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• オリゴヌクレオチド
• 酵素
• クローニングおよびアセンブリキット
• 異種核酸（XNA）
• シャーシ有機体
• 世界の合成生物学市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 医薬品および診断
• 化学薬品
• バイオ燃料
• バイオプラスチック
• その他の用途
• 世界の合成生物学市場、ヌクレオチド合成と配列決定のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• DNA合成技術
• 次世代シーケンシング（NGS）
• サンガーシーケンス
• 世界の合成生物学市場、バイオインフォマティクスのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ゲノムデータ分析のためのソフトウェアツール
• 遺伝子/タンパク質情報のデータベース
• 遺伝子編集と設計のためのアルゴリズム
• 世界の合成生物学市場、マイクロ流体のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ラボオンチップ技術
• 生物学的アッセイのためのマイクロ流体デバイス
• 創薬と診断における応用
• 世界の合成生物学市場、遺伝子工学のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• CRISPR/Cas9テクノロジー
• 組み換えDNA技術
• 合成遺伝子の構築と組み立て

第7章 地域別・国別分析

• 世界の合成生物学市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の合成生物学市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 合成生物学市場：競合情勢
• 合成生物学市場：企業プロファイル
  • Thermo Fisher Scientific Inc Overview, Products and Services, Strategy and Financial Analysis
  • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Eurofins Scientific Overview, Products and Services, Strategy and Financial Analysis
  • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • Novozymes A/S Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Agilent Technologies
• New England Biolabs Inc
• Precigen Inc
• Amyris, Inc
• Genscript Biotech Corporation
• Codex Genetics
• Cathay Biotech
• Bota Biosciences
• Bluepha
• Spiber
• OriCiro Genomics Inc
• Provectus Algae
• Puraffinity
• Royal DSM NV
• Colorifix

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 合成生物学市場2029：新たな機会を提供する国
• 合成生物学市場2029：新たな機会を提供するセグメント
• 合成生物学市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Synthetic biology is a branch of biological science that applies engineering principles to redesign organisms, endowing them with new functionalities. It can be viewed as the culmination or the deliberate, prescriptive stage of biology.

The primary product categories within synthetic biology include oligonucleotides, enzymes, cloning and assembly kits, xeno-nucleic acids (XNA), and chassis organisms. Oligonucleotides refer to small single-stranded DNA segments that, upon internalization by the cell, can selectively suppress the expression of a single protein. Various technologies, such as nucleotide synthesis and sequencing, bioinformatics, microfluidics, and genetic engineering, are employed in applications spanning pharmaceuticals and diagnostics, chemicals, biofuels, bioplastics, and other related fields.

The synthetic biology market research report is one of a series of new reports from The Business Research Company that provides synthetic biology market statistics, including synthetic biology industry global market size, regional shares, competitors with a synthetic biology market share, detailed synthetic biology market segments, market trends and opportunities, and any further data you may need to thrive in the synthetic biology industry. This synthetic biology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The synthetic biology market size has grown exponentially in recent years. It will grow from $21.13 billion in 2024 to $26.7 billion in 2025 at a compound annual growth rate (CAGR) of 26.3%. The growth in the historic period can be attributed to increasing healthcare and life science facilities, increasing investment in drug, wide application in end-user industries, low cost of dna sequencing and synthesizing, and rise in funding.

The synthetic biology market size is expected to see rapid growth in the next few years. It will grow to $54.27 billion in 2029 at a compound annual growth rate (CAGR) of 19.4%. The growth in the forecast period can be attributed to increasing government initiatives, demand for fuel alternatives, increase in demand for genetically modified crops, and increasing investments in private companies. Major trends in the forecast period include strategic collaborations and partnerships, automation in nucleotide synthesis and sequencing, rising focus on gene editing, product innovation rising adoption of cell-free technology, new environmentally friendly process for biofuel production.

The increasing investment in research and development (R&D) is expected to drive the growth of the synthetic biology market in the future. R&D involves the systematic investigation, experimentation, and innovation aimed at creating new knowledge, technologies, or products to enhance existing offerings or develop new ones. The rise in R&D investments is largely attributed to heightened competition, the demand for innovation, advancements in technology, and the necessity for businesses to adapt to evolving consumer preferences and market dynamics. Investment in R&D for synthetic biology is crucial for unlocking the field's potential to create sustainable solutions in healthcare, agriculture, and environmental management by engineering biological systems and organisms for specific applications. For example, in February 2024, a report from the Office for National Statistics, a UK-based government department, indicated that the pharmaceuticals product group was the top contributor to overall business R&D in the UK in 2022, accounting for $11.7 billion (£9.0 billion). This figure represented 17.9% of the total R&D conducted by UK businesses. Therefore, the increase in research and development investment is driving the growth of the synthetic biology market.

The rising demand for personalized medicine is poised to drive the growth of the synthetic biology market. Personalized medicine, also referred to as precision medicine, constitutes a category of medical treatments tailored to the specific characteristics of individual patients. Synthetic biology plays a crucial role in personalized medicine, offering potent tools and techniques to customize medical treatments and interventions based on an individual's distinct genetic and molecular profile. For instance, in 2023, the Personalized Medicine Coalition reported that in 2022, the FDA approved personalized medicines for 34% of new drugs. Over the previous eight years, these medicines were approved for at least 25% of new drugs. Thus, the escalating demand for personalized medicine emerges as a key driver for the growth of the synthetic biology market.

Recent technological advancements in DNA sequencing have empowered researchers to utilize DNA as a means to store non-genetic information. Given the escalating demand for data storage, DNA data storage presents a viable solution, with a single DNA strand capable of storing approximately 455 Exabytes of data (equivalent to 455 billion gigabytes). Consequently, this concept has attracted significant investments from market entities. Binary data, represented in 0s and 1s, is translated into DNA strings comprising four distinct base units-A, G, C, T (Adenine, Guanine, Cytosine, and Thymine). Notably, information encoded in DNA can endure for thousands of years, a remarkable contrast to traditional hard drives where data corruption or damage may occur within 30 years. For instance, a Nature Publishing Group journal reported that Microsoft and University of Washington researchers successfully stored over 200 megabytes of data, equivalent to 35 distinct digital files, in DNA. There are plans for increased investment to enhance this technology further.

Major companies active in the synthetic biology market are making strategic investments to drive innovation, research, and development in DNA synthesis technology. Investments in synthetic biology encompass financial backing and funding for companies and projects within this domain. In January 2022, Ribbon Biolabs GmbH, an Austrian biotechnology company, secured $19.12 million (approximately 18 million euros) in a series A funding round. This funding facilitated the establishment of commercial-scale manufacturing facilities and advancements in DNA synthesis technology in the United States. The potential outcomes include the development of new drugs, gene editing therapies, and personalized medicines, thereby improving the lives of numerous patients.

In July 2022, Ginkgo Bioworks, a US-based biotech company, completed the acquisition of Zymergen for $300 million. This strategic move is aimed at fortifying Ginkgo's platform, expanding its product portfolio, broadening its customer base, and achieving cost efficiencies. Zymergen, the acquired company, employs synthetic biology to create and manufacture various products, including materials, microbes, and therapeutics.

Major companies operating in the synthetic biology market include Thermo Fisher Scientific Inc, Danaher Corporation, Eurofins Scientific, Merck KGaA, Novozymes A/S, Agilent Technologies, New England Biolabs Inc, Precigen Inc, Amyris, Inc, Genscript Biotech Corporation, Codex Genetics, Cathay Biotech, Bota Biosciences, Bluepha, Spiber, OriCiro Genomics Inc, Provectus Algae, Puraffinity, Royal DSM NV, Colorifix, Phytoform Labs, Desktop Genetics, NanoSyrinx, Pulmobiotics S.L, EnginZyme, Chain Biotech, Nuclera Nucleics, Biosynthetics GmbH, Entelechon GmbH, Sloning BioTechnology GmbH, Prokarium Ltd, Synbio, Captor Therapeutics, Gero.ai, ARNA Genomics, Solvo Omixon, Soft flow, Algenol, Genomatica, Integrated DNA Technologies, Sana Biotechnology, Impossible Foods, Apeel Sciences, Twist Bioscience, Synlogic, Zymergen Inc, Ginkgo Bioworks, Codexis, Arzeda Corporation, Synthetic Genomics, Conagen, Dupont, Oxitec Ltd, Sentebiolab, GEEN Biotechnology Inc, Genbiotek Biosistem Laboratory Ltd

North America was the largest region in the synthetic biology market in 2024. Western Europe was the second largest region in the global synthetic biology market share. The regions covered in the synthetic biology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the synthetic biology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The synthetic biology market includes revenue earned by synthetic compound, technology and related services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Synthetic Biology Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on synthetic biology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for synthetic biology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The synthetic biology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Technology: Nucleotide Synthesis And Sequencing, Bioinformatics, Microfluidics, Genetic Engineering
• 3) By Product Type: Oligonucleotides, Enzymes, Cloning And Assembly Kits, Xeno-Nucleic Acids (XNA), Chassis Organism
• 2) By Application: Pharmaceuticals And Diagnostics, Chemicals, Biofuels, Bioplastics, Other Application
• Subsegments:
• 1) By Nucleotide Synthesis And Sequencing: DNA Synthesis Technologies; Next-Generation Sequencing (NGS); Sanger Sequencing
• 2) By Bioinformatics: Software Tools For Genomic Data Analysis; Databases For Gene/Protein Information; Algorithms For Gene Editing And Design
• 3) By Microfluidics: Lab-On-A-Chip Technologies; Microfluidic Devices For Biological Assays; Applications In Drug Discovery And Diagnostics
• 4) By Genetic Engineering: CRISPR/Cas9 Technology; Recombinant DNA Technology; Synthetic Gene Construction And Assembly
• Companies Mentioned: Thermo Fisher Scientific Inc; Danaher Corporation; Eurofins Scientific; Merck KGaA; Novozymes A/S
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Synthetic Biology Market Characteristics

3. Synthetic Biology Market Trends And Strategies

4. Synthetic Biology Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Synthetic Biology Growth Analysis And Strategic Analysis Framework

• 5.1. Global Synthetic Biology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Synthetic Biology Market Growth Rate Analysis
• 5.4. Global Synthetic Biology Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Synthetic Biology Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Synthetic Biology Total Addressable Market (TAM)

6. Synthetic Biology Market Segmentation

• 6.1. Global Synthetic Biology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Nucleotide Synthesis And Sequencing
• Bioinformatics
• Microfluidics
• Genetic Engineering
• 6.2. Global Synthetic Biology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oligonucleotides
• Enzymes
• Cloning and Assembly Kits
• Xeno-nucleic Acids (XNA)
• Chassis Organism
• 6.3. Global Synthetic Biology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmaceuticals And Diagnostics
• Chemicals
• Biofuels
• Bioplastics
• Other Applications
• 6.4. Global Synthetic Biology Market, Sub-Segmentation Of Nucleotide Synthesis And Sequencing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• DNA Synthesis Technologies
• Next-Generation Sequencing (NGS)
• Sanger Sequencing
• 6.5. Global Synthetic Biology Market, Sub-Segmentation Of Bioinformatics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Software Tools For Genomic Data Analysis
• Databases For Gene/Protein Information
• Algorithms For Gene Editing And Design
• 6.6. Global Synthetic Biology Market, Sub-Segmentation Of Microfluidics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Lab-On-A-Chip Technologies
• Microfluidic Devices For Biological Assays
• Applications In Drug Discovery And Diagnostics
• 6.7. Global Synthetic Biology Market, Sub-Segmentation Of Genetic Engineering, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• CRISPR/Cas9 Technology
• Recombinant DNA Technology
• Synthetic Gene Construction And Assembly

7. Synthetic Biology Market Regional And Country Analysis

• 7.1. Global Synthetic Biology Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Synthetic Biology Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Synthetic Biology Market

• 8.1. Asia-Pacific Synthetic Biology Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Synthetic Biology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Synthetic Biology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Synthetic Biology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Synthetic Biology Market

• 9.1. China Synthetic Biology Market Overview
• 9.2. China Synthetic Biology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Synthetic Biology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Synthetic Biology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Synthetic Biology Market

• 10.1. India Synthetic Biology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Synthetic Biology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Synthetic Biology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Synthetic Biology Market

• 11.1. Japan Synthetic Biology Market Overview
• 11.2. Japan Synthetic Biology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Synthetic Biology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Synthetic Biology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Synthetic Biology Market

• 12.1. Australia Synthetic Biology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Synthetic Biology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Synthetic Biology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Synthetic Biology Market

• 13.1. Indonesia Synthetic Biology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Synthetic Biology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Synthetic Biology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Synthetic Biology Market

• 14.1. South Korea Synthetic Biology Market Overview
• 14.2. South Korea Synthetic Biology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Synthetic Biology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Synthetic Biology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Synthetic Biology Market

• 15.1. Western Europe Synthetic Biology Market Overview
• 15.2. Western Europe Synthetic Biology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Synthetic Biology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Synthetic Biology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Synthetic Biology Market

• 16.1. UK Synthetic Biology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Synthetic Biology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Synthetic Biology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Synthetic Biology Market

• 17.1. Germany Synthetic Biology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Synthetic Biology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Synthetic Biology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Synthetic Biology Market

• 18.1. France Synthetic Biology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Synthetic Biology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Synthetic Biology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Synthetic Biology Market

• 19.1. Italy Synthetic Biology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Synthetic Biology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Synthetic Biology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Synthetic Biology Market

• 20.1. Spain Synthetic Biology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Synthetic Biology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Synthetic Biology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Synthetic Biology Market

• 21.1. Eastern Europe Synthetic Biology Market Overview
• 21.2. Eastern Europe Synthetic Biology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Synthetic Biology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Synthetic Biology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Synthetic Biology Market

• 22.1. Russia Synthetic Biology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Synthetic Biology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Synthetic Biology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Synthetic Biology Market

• 23.1. North America Synthetic Biology Market Overview
• 23.2. North America Synthetic Biology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Synthetic Biology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Synthetic Biology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Synthetic Biology Market

• 24.1. USA Synthetic Biology Market Overview
• 24.2. USA Synthetic Biology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Synthetic Biology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Synthetic Biology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Synthetic Biology Market

• 25.1. Canada Synthetic Biology Market Overview
• 25.2. Canada Synthetic Biology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Synthetic Biology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Synthetic Biology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Synthetic Biology Market

• 26.1. South America Synthetic Biology Market Overview
• 26.2. South America Synthetic Biology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Synthetic Biology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Synthetic Biology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Synthetic Biology Market

• 27.1. Brazil Synthetic Biology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Synthetic Biology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Synthetic Biology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Synthetic Biology Market

• 28.1. Middle East Synthetic Biology Market Overview
• 28.2. Middle East Synthetic Biology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Synthetic Biology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Synthetic Biology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Synthetic Biology Market

• 29.1. Africa Synthetic Biology Market Overview
• 29.2. Africa Synthetic Biology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Synthetic Biology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Synthetic Biology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Synthetic Biology Market Competitive Landscape And Company Profiles

• 30.1. Synthetic Biology Market Competitive Landscape
• 30.2. Synthetic Biology Market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Inc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Eurofins Scientific Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Novozymes A/S Overview, Products and Services, Strategy and Financial Analysis

31. Synthetic Biology Market Other Major And Innovative Companies

• 31.1. Agilent Technologies
• 31.2. New England Biolabs Inc
• 31.3. Precigen Inc
• 31.4. Amyris, Inc
• 31.5. Genscript Biotech Corporation
• 31.6. Codex Genetics
• 31.7. Cathay Biotech
• 31.8. Bota Biosciences
• 31.9. Bluepha
• 31.10. Spiber
• 31.11. OriCiro Genomics Inc
• 31.12. Provectus Algae
• 31.13. Puraffinity
• 31.14. Royal DSM NV
• 31.15. Colorifix

32. Global Synthetic Biology Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Synthetic Biology Market

34. Recent Developments In The Synthetic Biology Market

35. Synthetic Biology Market High Potential Countries, Segments and Strategies

• 35.1 Synthetic Biology Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Synthetic Biology Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Synthetic Biology Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer